Institutional Biosafety Committee – IBC

Federal Guidelines established by the National Institute of Health, require that institutions conducting or sponsoring research using recombinant or synthetic nucleic acid molecules covered by the NIH Guidelines, be responsible for ensuring that the research is conducted in full conformity with the provisions of those guidelines. In order to fulfill this responsibility, UA Little Rock has established an Institutional Biosafety Committee (IBC), charged with oversight responsibilities for all research related activities involving recombinant or synthetic nucleic acid molecules and other biohazardous materials.

The IBC is responsible for reviewing and approving those research and teaching activities conducted by faculty, staff, and students at UA Little Rock that involve the use of biohazardous materials including regulated animal and plant pathogens, biological toxins, and recombinant or synthetic nucleic acid molecules.

Submit IBC Protocol for Review

For more information contact:
Nawab Ali, PhD
Associate Research Professor of Biology & IBC Chair
University of Arkansas at Little Rock
501-247-3248. |